We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBH icon
1351
Prestige Consumer Healthcare
PBH
$2.38B
$6.97M 0.01%
125,896
+83,546
+197% +$4.6M
RVTY icon
1352
Revvity
RVTY
$12.6B
$6.97M 0.01%
133,047
+32,755
+33% +$1.72M
ILF icon
1353
iShares Latin America 40 ETF
ILF
$3.85B
$6.97M 0.01%
265,258
+4,153
+2% +$105K
SABR icon
1354
Sabre
SABR
$731M
$6.97M 0.01%
260,041
+73,390
+39% +$2.06M
BCPC
1355
Balchem Corp
BCPC
$5.38B
$6.95M 0.01%
116,445
+50,276
+76% +$3.07M
ESV
1356
DELISTED
Ensco Rowan plc
ESV
$6.95M 0.01%
178,829
+45,521
+34% +$1.89M
BIG
1357
DELISTED
Big Lots, Inc.
BIG
$6.92M 0.01%
138,095
+66,606
+93% +$3.16M
PNRA
1358
DELISTED
Panera Bread Co
PNRA
$6.92M 0.01%
32,635
+3,377
+12% +$719K
MRK icon
1359
PUT
Merck
MRK
$322B
$6.91M 0.01%
+125,760
New +$6.69M
IMS
1360
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$6.91M 0.01%
272,571
+65,628
+32% +$1.68M
HDS
1361
DELISTED
HD Supply Holdings, Inc.
HDS
$6.91M 0.01%
198,392
+24,746
+14% +$843K
RARE icon
1362
Ultragenyx Pharmaceutical
RARE
$2.45B
$6.91M 0.01%
141,187
+56,038
+66% +$3.62M
NKTR icon
1363
Nektar Therapeutics
NKTR
$2.39B
$6.9M 0.01%
32,343
+6,204
+24% +$1.39M
KYNB
1364
Kyntra Bio
KYNB
$27.2M
$6.9M 0.01%
16,807
+185
+1% +$84.7K
HL icon
1365
Hecla Mining
HL
$9.47B
$6.88M 0.01%
1,349,339
+38,002
+3% +$154K
AFG icon
1366
American Financial Group
AFG
$11.8B
$6.88M 0.01%
93,077
-77,105
-45% -$5.46M
SPB icon
1367
Spectrum Brands
SPB
$2.04B
$6.85M 0.01%
57,403
+34,216
+148% +$3.93M
N
1368
DELISTED
Netsuite Inc
N
$6.84M 0.01%
94,001
+51,474
+121% +$3.95M
BECN
1369
DELISTED
Beacon Roofing Supply, Inc.
BECN
$6.83M 0.01%
150,130
+19,494
+15% +$839K
MU icon
1370
CALL
Micron Technology
MU
$930B
$6.81M 0.01%
495,000
+45,000
+10% +$511K
SNCR
1371
DELISTED
Synchronoss Technologies
SNCR
$6.81M 0.01%
23,752
+4,908
+26% +$1.48M
PSB
1372
DELISTED
PS Business Parks, Inc.
PSB
$6.8M 0.01%
64,135
+10,406
+19% +$1.04M
SHV icon
1373
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$6.79M 0.01%
+61,485
New +$6.79M
LVNTA
1374
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$6.79M 0.01%
183,132
-23,425
-11% -$890K
WDR
1375
DELISTED
Waddell & Reed Financial, Inc.
WDR
$6.79M 0.01%
394,051
+225,696
+134% +$4.61M

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.